‘Confusion’ Clogs Sunscreen TEA Proposals, ‘Radio Silence’ On NSURE Progress – Woodcock
This article was originally published in The Tan Sheet
Executive Summary
At a CHPA conference in Washington, the CDER director elaborates on the center’s work on OTC monograph modernization and the NSURE initiative in addition to sunscreen ingredient TEAs. Use in foreign countries means only that a sunscreen ingredient is eligible to be proposed for FDA consideration, she says.
You may also be interested in...
Room For Innovative Switches Could Lurk In Existing FDA Framework
When firms suggest submitting switch NDAs for “something that would be worth engaging on, we’re not going to tell you no,” says FDA nonprescription drug program chief Theresa Michele.
Chronic Conditions Data Emphasize Need For Additional, Innovative OTCs
An NIH-funded study shows 92% of older consumers have chronic conditions, the primary target of FDA’s Nonprescription Safe Use Regulatory Expansion initiative to facilitate more Rx-to-OTC switches. The agency also extends the comment period for its initiative on making more ingredients available through the OTC monograph process.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.